ArticleThe journal of headache and pain2020

Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway.

Amanda Hansson-Hedblom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.